T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) and Lymphocyte-activation gene 3 (LAG-3) are newly established T cell checkpoints and targets for cancer therapy, with studies suggesting an emerging role for these proteins in NK cells [116]. The gene discussed is LAG3; the disease is cancer.